P008 Real-world analysis of the clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage node positive breast cancer in Ireland by I.M. Browne, R.A. McLaughlin, R.S. Prichard, D.P. McCartan, S.J. Millen, M.J. Higgins, J.P. Crown, B.T. Hennessy, C.M. Quinn, P.G. Morris, J.M. Walshe

Get full text